Novartis Buys Gene Therapy Co. Avexis In $8.7B Deal
Novartis on Monday said it will pay a $8.7 billion to take over gene therapy company Avexis Inc. in a deal that will allow the health and life sciences giant to...To view the full article, register now.
Already a subscriber? Click here to view full article